"cost effectiveness analysis" trang 3 - tải miễn phí từ tailieuXANH
Báo cáo y học:

Báo cáo y học: "Cost-effectiveness analysis for joint pain treatment in patients with osteoarthritis treated at the Instituto Mexicano del Seguro Social (IMSS): Comparison of nonsteroidal anti-inflammatory drugs (NSAIDs) vs. cyclooxygenase-2 selective inhibitor"
13    48    0
Báo cáo y học:

Báo cáo y học: " Cost-effectiveness analysis of the available strategies for diagnosing malaria in outpatient clinics in Zambia"
12    47    0
Báo cáo y học:

Báo cáo y học: "Prevention, screening and treatment of colorectal cancer: a global and regional generalized cost effectiveness analysis"
16    60    0
Báo cáo y học:

Báo cáo y học: "Cost-effectiveness analysis of clinical specialist outreach as compared to referral system in Ethiopia: an economic evaluation"
6    51    0
Báo cáo y học:

Báo cáo y học: "Generalized cost-effectiveness analysis for national-level priority-setting in the health sector"
13    54    0
Báo cáo y học:

Báo cáo y học: "Is cost-effectiveness analysis preferred to severity of disease as the main guiding principle in priority setting in resource poor settings"
11    37    0
Báo cáo y học:

Báo cáo y học: " Implications of ICU triage decisions on patient mortality: a cost-effectiveness analysis"
9    52    0
The Entrepreneurial Event Revisited: firm formation in a regional context

The Entrepreneurial Event Revisited: firm formation in a regional context
1    66    0
An economic analysis of human milk supplementation for very low birth weight babies in the USA

An economic analysis of human milk supplementation for very low birth weight babies in the USA
9    58    0
Protocol for a phase III RCT and economic analysis of two exercise delivery methods in men with PC on ADT

Protocol for a phase III RCT and economic analysis of two exercise delivery methods in men with PC on ADT
18    75    0
A phase II RCT and economic analysis of three exercise delivery methods in men with prostate cancer on androgen deprivation therapy

A phase II RCT and economic analysis of three exercise delivery methods in men with prostate cancer on androgen deprivation therapy
11    58    0
Real world costs and cost-effectiveness of Rituximab for diffuse large B-cell lymphoma patients: A population-based analysis

Real world costs and cost-effectiveness of Rituximab for diffuse large B-cell lymphoma patients: A population-based analysis
11    55    0
Gene-guided Gefitinib switch maintenance therapy for patients with advanced EGFR mutation-positive Non-small cell lung cancer: An economic analysis

Gene-guided Gefitinib switch maintenance therapy for patients with advanced EGFR mutation-positive Non-small cell lung cancer: An economic analysis
11    82    0
Clinical and cost effectiveness of arthritis gloves in rheumatoid arthritis (A-GLOVES): Randomised controlled trial with economic analysis

Clinical and cost effectiveness of arthritis gloves in rheumatoid arthritis (A-GLOVES): Randomised controlled trial with economic analysis
13    42    0
PSMA PET/CT guided intensification of therapy in patients at risk of advanced prostate cancer (PATRON): A pragmatic phase III randomized controlled trial

PSMA PET/CT guided intensification of therapy in patients at risk of advanced prostate cancer (PATRON): A pragmatic phase III randomized controlled trial
11    13    1
Economic evaluation of continuous subcutaneous insulin infusion for children with diabetes - a pilot study: CSII application for children – economic evaluation

Economic evaluation of continuous subcutaneous insulin infusion for children with diabetes - a pilot study: CSII application for children – economic evaluation
6    42    0
Clinical and economic impact of ‘ROS1- testing’ strategy compared to a ‘no-ROS1-testing’ strategy in advanced NSCLC in Spain

Clinical and economic impact of ‘ROS1- testing’ strategy compared to a ‘no-ROS1-testing’ strategy in advanced NSCLC in Spain
13    25    1
Cost effectiveness analysis of afatinib versus pemetrexed-cisplatin for first-line treatment of locally advanced or metastatic EGFR mutation positive non-small-cell lung cancer from the Singapore healthcare payer’s perspective

Cost effectiveness analysis of afatinib versus pemetrexed-cisplatin for first-line treatment of locally advanced or metastatic EGFR mutation positive non-small-cell lung cancer from the Singapore healthcare payer’s perspective
10    80    0
Cost-effectiveness analysis comparing companion diagnostic tests for EGFR, ALK, and ROS1 versus next-generation sequencing (NGS) in advanced adenocarcinoma lung cancer patients

Cost-effectiveness analysis comparing companion diagnostic tests for EGFR, ALK, and ROS1 versus next-generation sequencing (NGS) in advanced adenocarcinoma lung cancer patients
10    71    0
Cost-effectiveness-analysis of ultrasound guidance for central venous catheterization compared with landmark method: A decision-analytic model

Cost-effectiveness-analysis of ultrasound guidance for central venous catheterization compared with landmark method: A decision-analytic model
10    239    1
Đã phát hiện trình chặn quảng cáo AdBlock
Trang web này phụ thuộc vào doanh thu từ số lần hiển thị quảng cáo để tồn tại. Vui lòng tắt trình chặn quảng cáo của bạn hoặc tạm dừng tính năng chặn quảng cáo cho trang web này.